| CAS登錄號 | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 69712-56-7 | 頭孢替坦; (6R,7S)-7-[[4-(1-氨基-3-羥基-1,3-二氧代丙烷-2-基亞基)1,3-二硫雜環(huán)丁烷-2-甲酰]氨基]-7-甲氧基 | Cefotetan; (6R,7S)-7-[[4-(1-Amino-3-hydroxy-1,3-dioxopropan-2-ylidene)1,3-dithietane-2-carbonyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic a |  | C17H17N7O8S4 | 詳情 | 供應(yīng)商 |
| 5907-92-6 | Alaninamide,N-(L-2-ethoxyhexanoyl)glycyl-L-tryptophyl-L-methionyl-L-aspartylphenyl-, L-(7CI,8CI) |  | C39H53N7O8S | 詳情 | 供應(yīng)商 | |
| 182828-62-2 | Allatostatin 1(Schistocerca gregaria) (9CI); L-Valinamide,L-leucyl-L-cysteinyl-L-a-aspartyl-L-phenylalanylglycyl-; Schistostatin 1 |  | C29H45N7O8S | 詳情 | 供應(yīng)商 | |
| 79953-10-9 | Benzenesulfonic acid,4-[3-(6,9-dihydro-6-oxo-9-b-D-ribofuranosyl-1H-purin-2-yl)-1-triazenyl]- (9CI) |  | C16H17N7O8S | 詳情 | 供應(yīng)商 | |
| 141076-16-6 | Guanosine,2'-deoxy-6-S-(2,4-dinitrophenyl)-N-(phenylacetyl)-6-thio- (9CI); S6-(2,4-DINITROPHENYL)-N2-PHENYLACETYL-2''-DEOXYTHIOGUANOSINE |  | C24H21N7O8S | 詳情 | 供應(yīng)商 | |
| 75909-25-0 | L-Lysine,L-tyrosylglycylglycyl-L-phenylalanyl-L-methionyl-; L-Lysine,N2-[N-[N-[N-(N-L-tyrosylglycyl)glycyl]-L-phenylalanyl]-L-methionyl]-; 181: PN:WO0069900 SEQID: 847 unclaimed sequence; 44: PN: WO0222860 SEQID: 41 unclaimedsequence; 684: PN: US20090175821 SEQID: 847 claimed protein; Lys6-Met5-enkephalin; Met5-Lys6-enkephalin |  | C33H47N7O8S | 詳情 | 供應(yīng)商 | |
| 123067-53-8 | L-Methioninamide, L-a-glutamyl-L-phenylalanyl-L-phenylalanylglycyl-L-leucyl-(9CI); substance P (6-11), Glu(6)- |  | C36H51N7O8S | 詳情 | 供應(yīng)商 | |
| 69557-39-7 | L-Alanine,L-lysyl-L-cysteinyl-L-threonyl-L-cysteinyl-L-cysteinyl-; L-Alanine,N-[N-[N-[N-(N-L-lysyl-L-cysteinyl)-L-threonyl]-L-cysteinyl]-L-cysteinyl]-; 4: PN:CN1376719 PAGE: 4 unclaimed sequence |  | C22H41N7O8S3 | 詳情 | 供應(yīng)商 | |
| 254451-42-8 | NEURODYE RH-155; NEURODYE RH-155; RH 155; TRI(N,N-DIETHYL-1-ETHANAMINIUM) 4-(3-METHYL-4-((E,2Z,4E)-5-[3-METHYL-5-OXIDO-1-(4-SULFONATOPHENYL)-1H-PYRAZOL-4-YL]-3-PHENYL-2,4-PENTADIENYLIDENE)-5-OXO-4,5-DIHYDRO-1H-PYRAZOL-1-YL)BENZENESULFONATE; 4,4'-BIS(1-(4-SULFOPHENYL-3-METHYLPYRAZOLE-5-ONE)MESOPHENYL-PENTAMETHINEOXONOL); BENZENESULFONIC ACID, 4-[4,5-DIHYDRO-4-[5-[5-HYDROXY-3-METHYL-1-(4-SULFOPHENYL)-1H-PYRAZOL-4-YL]-3-PHENYL-2,4-PENTADIENYLIDENE]-3-METHYL-5-OXO-1H-PYRAZOL-1-YL]-, N,N-DIETHYLETHANAMINE (1:3); (4,4'-bis(1-(4-sulfophenyl-3-methylpyrazole-5-one)mesophenylpentamethineoxonol triethylamine salt; NEURODYE RH-155, PURE; 4-[5-Hydroxy-3-methyl-4-[3-phenyl-5-[[1-(4-sulfophenyl)-3-methyl-4,5-dihydro-5-oxo-1H-pyrazol]-4-ylidene]-1,4-pentadienyl]-1H-pyrazol-1-yl]benzenesulfonic acid |  | C49H71N7O8S2 | 詳情 | 供應(yīng)商 | |
| 872728-81-9 | 達(dá)比加群酯; 甲磺酸達(dá)比加群酯 | N-[[2-[[[4-[[[(Hexyloxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-y; Dabigatran etexilate mesylate; N-[[2-[[[4-[[[(Hexyloxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-beta-alanine ethyl ester monomethanesulfonat; Pradaxa |  | C35H45N7O8S | 詳情 | 供應(yīng)商 |